Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II.
作者信息
Mikov Momir, Đanić Maja, Lazarević Slavica, Pavlović Nebojša, Stanimirov Bojan, Al-Salami Hani, Mooranian Armin
机构信息
Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
出版信息
Front Pharmacol. 2023 Jan 4;13:1087988. doi: 10.3389/fphar.2022.1087988. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II.
Front Pharmacol. 2023 Jan 4;13:1087988. doi: 10.3389/fphar.2022.1087988. eCollection 2022.
2
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen.
Pharmaceutics. 2020 Nov 2;12(11):1049. doi: 10.3390/pharmaceutics12111049.
3
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.
AAPS J. 2017 Jan;19(1):26-42. doi: 10.1208/s12248-016-0010-3. Epub 2016 Nov 10.
4
Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
Eur J Pharm Sci. 2013 Aug 16;49(5):819-28. doi: 10.1016/j.ejps.2013.06.009. Epub 2013 Jun 24.
5
Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
Mol Pharm. 2017 Dec 4;14(12):4305-4320. doi: 10.1021/acs.molpharmaceut.7b00406. Epub 2017 Aug 25.
6
In Vitro-In Vivo Correlation Using In Silico Modeling of Physiological Properties, Metabolites, and Intestinal Metabolism.
Curr Drug Metab. 2017;18(11):973-982. doi: 10.2174/1389200218666171031124347.
7
Evaluation of the whole body physiologically based pharmacokinetic (WB-PBPK) modeling of drugs.
J Theor Biol. 2018 Aug 14;451:1-9. doi: 10.1016/j.jtbi.2018.04.032. Epub 2018 Apr 26.
8
Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.
Toxicol Sci. 2019 Jun 1;169(2):365-379. doi: 10.1093/toxsci/kfz042.
9
Analysis of Time-Dependent Pharmacokinetics Using In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling.
Pharmaceutics. 2022 Nov 22;14(12):2562. doi: 10.3390/pharmaceutics14122562.
10
Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico-in vivo extrapolation and physiologically-based pharmacokinetic modeling approach.
J Pharmacol Toxicol Methods. 2013 May-Jun;67(3):203-13. doi: 10.1016/j.vascn.2012.12.002. Epub 2012 Dec 29.
引用本文的文献
1
Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites.
Front Pharmacol. 2024 Dec 3;15:1492284. doi: 10.3389/fphar.2024.1492284. eCollection 2024.
本文引用的文献
1
PBPK Modeling as a Tool for Predicting and Understanding Intestinal Metabolism of Uridine 5'-Diphospho-glucuronosyltransferase Substrates.
Pharmaceutics. 2021 Aug 24;13(9):1325. doi: 10.3390/pharmaceutics13091325.
2
In vitro - In vivo correlation in the development of oral drug formulation: A screenshot of the last two decades.
Int J Pharm. 2020 Apr 30;580:119210. doi: 10.1016/j.ijpharm.2020.119210. Epub 2020 Mar 12.
3
Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling.
J Clin Pharmacol. 2020 Jul;60(7):915-930. doi: 10.1002/jcph.1584. Epub 2020 Feb 20.
4
In Vitro-In Vivo Correlations Based on In Vitro Dissolution of Parent Drug Diltiazem and Pharmacokinetics of its Metabolite.
Pharmaceutics. 2019 Jul 16;11(7):344. doi: 10.3390/pharmaceutics11070344.
5
Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin.
Drug Metab Dispos. 2018 Feb;46(2):109-121. doi: 10.1124/dmd.117.078006. Epub 2017 Nov 8.
6
Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models.
Pharmaceutics. 2017 Sep 26;9(4):41. doi: 10.3390/pharmaceutics9040041.
7
Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.
Clin Pharmacol Ther. 2015 Mar;97(3):247-62. doi: 10.1002/cpt.37. Epub 2015 Jan 9.
Zotero 插件